Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer
Authors
Keywords
-
Journal
GUT
Volume 65, Issue 8, Pages 1296-1305
Publisher
BMJ
Online
2015-04-29
DOI
10.1136/gutjnl-2014-309026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microsatellite Instability Detection by Next Generation Sequencing
- (2014) S. J. Salipante et al. CLINICAL CHEMISTRY
- ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
- (2014) Anais Laforest et al. EUROPEAN JOURNAL OF CANCER
- Defining HNPCC and Lynch syndrome: what's in a name?: Table 1
- (2014) S E Kravochuck et al. GUT
- The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers
- (2014) Tae-Min Kim et al. JOURNAL OF PATHOLOGY
- FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
- (2014) Volker Heinemann et al. LANCET ONCOLOGY
- The BRAF Oncoprotein Functions through the Transcriptional Repressor MAFG to Mediate the CpG Island Methylator Phenotype
- (2014) Minggang Fang et al. MOLECULAR CELL
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes
- (2013) Tae-Min Kim et al. CELL
- Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
- (2013) Hans F A Vasen et al. GUT
- Implementation of Universal Microsatellite Instability and Immunohistochemistry Screening for Diagnosing Lynch Syndrome in a Large Academic Medical Center
- (2013) Brandie Heald et al. JOURNAL OF CLINICAL ONCOLOGY
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Approach for Characterizing Microsatellite Instability in Cancer Cells
- (2013) Yuheng Lu et al. PLoS One
- Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
- (2012) H. Thorvaldsdottir et al. BRIEFINGS IN BIOINFORMATICS
- Correlation of tumour BRAF mutations andMLH1methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification
- (2012) Michael T Parsons et al. JOURNAL OF MEDICAL GENETICS
- Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
- (2012) Anirudh Prahallad et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
- (2012) Ron Bose et al. Cancer Discovery
- Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer
- (2011) Lucía Pérez-Carbonell et al. GUT
- Predicting the functional impact of protein mutations: application to cancer genomics
- (2011) Boris Reva et al. NUCLEIC ACIDS RESEARCH
- Differential Sensitivity of ERBB2 Kinase Domain Mutations towards Lapatinib
- (2011) Rama Krishna Kancha et al. PLoS One
- Fast and accurate long-read alignment with Burrows–Wheeler transform
- (2010) Heng Li et al. BIOINFORMATICS
- Colorectal cancer molecular biology moves into clinical practice
- (2010) C. C. Pritchard et al. GUT
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
- (2010) Wendy De Roock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Relevance of Microsatellite Instability in Colorectal Cancer
- (2010) Albert de la Chapelle et al. JOURNAL OF CLINICAL ONCOLOGY
- The Sequence Alignment/Map format and SAMtools
- (2009) H. Li et al. BIOINFORMATICS
- Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal Cancer
- (2009) Salvatore Siena et al. JNCI-Journal of the National Cancer Institute
- EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation
- (2008) T. Trowe et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started